GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enlitic Inc (ASX:ENL) » Definitions » EBITDA Margin %

Enlitic (ASX:ENL) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Enlitic EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Enlitic's EBITDA for the three months ended in . 20 was A$0.00 Mil. Enlitic's Revenue for the three months ended in . 20 was A$0.00 Mil. Therefore, Enlitic's EBITDA margin for the quarter that ended in . 20 was 0.00%.


Enlitic EBITDA Margin % Historical Data

The historical data trend for Enlitic's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enlitic EBITDA Margin % Chart

Enlitic Annual Data
Trend Dec23
EBITDA Margin %
-3,056.95

Enlitic Quarterly Data
Dec23
EBITDA Margin % -

Competitive Comparison of Enlitic's EBITDA Margin %

For the Health Information Services subindustry, Enlitic's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enlitic's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Enlitic's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Enlitic's EBITDA Margin % falls into.



Enlitic EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Enlitic's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-22.652/0.741
=-3,056.95 %

Enlitic's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enlitic  (ASX:ENL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Enlitic EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Enlitic's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Enlitic (ASX:ENL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
3420 East Harmony Road, Suite 125, Fort Collins, CO, USA, 80528
Enlitic Inc is focused on artificial intelligence that enables effective administration, processing, and sharing of medical imaging data throughout the healthcare enterprise. It is also focused on developing tools that solve longstanding challenges in radiology rather than developing point solutions that exacerbate the issues radiology faces. Enlitic provides a solid plan that addresses data inconsistencies and risk associated with moving studies containing PHI and is focused on using AI for the medical imaging layer of a real-world evidence (RWE), providing healthcare organizations with a stepwise approach to operationalizing their AI.

Enlitic (ASX:ENL) Headlines

No Headlines